Clinical prevention of breast and prostate cancers.

被引：0
|
作者：
Greenwald, P [1 ]
机构：
[1] NCI, Bethesda, MD 20892 USA
来源：
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION | 2004年 / 13卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1953S / 1953S
页数：1
相关论文
共 50 条
  • [21] A DNA repair biomarker signature to predict radiotherapy side-effects in breast and prostate cancers.
    Muggiolu, Giovanna
    Libert, Libert
    Daguenet, Elisabeth
    Maillet, Thierry
    Rodriguez-Lafrasse, Claire
    Sauvaigo, Sylvie
    Magne, Nicolas
    CANCER RESEARCH, 2021, 81 (13)
  • [22] Expression analysis of chromosome 20 genes in prostate cancers.
    Wang, L
    Monahan, J
    Cheville, J
    Elkins, DA
    Wonsey, A
    Cunningham, JM
    Schaid, DJ
    Schlegel, R
    Thibodeau, SN
    AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 69 (04) : 262 - 262
  • [23] Clinical trials of breast and prostate cancer prevention
    Greenwald, P
    JOURNAL OF NUTRITION, 2001, 131 (01): : 176S - 178S
  • [24] Conformational radiotherapy of localized prostate cancers.: Preliminary results
    Pontvert, D.
    Jourdan-Da Silva, N.
    Gaboriaud, G.
    Mammar, H.
    Flam, T.
    Thiounn, N.
    Beuzeboc, P.
    Debre, B.
    BULLETIN DU CANCER, 2007, 94 (06) : 598 - 598
  • [25] Clinical sequencing in patients with refractory advanced cancers.
    Hijikata, Yasuki
    Yokoyama, Kazuaki
    Yamaguchi, Kiyoshi
    Ikenoue, Tsuneo
    Yamaguchi, Rui
    Imoto, Seiya
    Uchimaru, Kaoru
    Miyano, Satoru
    Yotsuyanagi, Hiroshi
    Tojo, Arinobu
    Furukawa, Yoichi
    CANCER SCIENCE, 2021, 112 : 323 - 323
  • [26] Different clinical characteristics in biliary tract cancers.
    Lee, MA
    Woo, IS
    Kang, JH
    Hong, YS
    Lee, KS
    Kim, DG
    Kim, SN
    Park, SY
    Kim, SY
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 361S - 361S
  • [27] Clinical value of FDG PET in skin cancers.
    Cho, SB
    Chung, KY
    Lee, JD
    Yun, M
    JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (05) : 404P - 404P
  • [28] Deprivation and pathological prognostic factors in operable breast cancers.
    Sharp, CM
    Wilson, C
    Angerson, W
    Mallon, EA
    Doughty, JC
    George, DW
    BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 : S48 - S48
  • [29] Mutation position in BRCA-associated breast cancers.
    Bernstam, F. Meic
    Gutierrez-Barrera, A.
    Litton, J. K.
    Mellor-Crummey, L.
    Ready, K.
    Gonzalez-Angulo, A. M.
    Lu, K. H.
    Hortobagyi, G. N.
    Arun, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [30] A Novel Prognostic Marker for Triple Negative Breast Cancers.
    Wallon, U. M.
    Sabol, J. L.
    Zemba-Palko, V.
    Carp, N. Z.
    Ciocca, R. M.
    Wojciechowski, B. S.
    Prendergast, G. C.
    CANCER RESEARCH, 2011, 71
12345